Quanterix Corporation Common Stock (QTRX)
Stock · NASDAQ · Industrials
$2.87as of 10/16/2026
Price chart
Active signals
QTRX Signal Track Record
How signals performed across all stocks →What QTRX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 38 | -5.1% | 45% | September 1, 2026 |
| Bollinger Band Breakout | 23 | -9.4% | 35% | September 17, 2026 |
| Bollinger Band Breakdown | 23 | -4.8% | 35% | July 28, 2026 |
| 200-Day Moving Average TouchActive now | 9 | -7.9% | 33% | March 3, 2026 |
| Any 20-session window (baseline) | -2.2% | 46% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About QTRX
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemi…
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Employees
- 450
- Website
- www.quanterix.com/
Fundamentals
- 1-day range
- $2.93$3.07
- Market cap
- $180.42M
- P/E (trailing)
- —
- P/E (forward)
- -2.18
- EPS (trailing)
- $-2.63
- Dividend yield
- —
- Beta
- 0.97
- Avg. volume
- 754.0K
How Quanterix Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 2, 2026 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
Quanterix Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- QTRXQuanterix Corporation Common Stock$2.87▼ 6.51%Market cap $180.42MP/E —$2.15$8.77
- SEERSeer Inc. Class A Common Stock$2.03▼ 0.49%Market cap $120.41MP/E —$1.55$2.41
- NAUTNautilus Biotechnology Inc. Common Stock$2.06▼ 4.63%Market cap $112.76MP/E —$0.8399$4.31
- RPIDRapid Micro Biosystems Inc. Class A Common Stock$0.764▼ 9.59%Market cap $96.03MP/E —$0.8087$4.94
- CIRCCircle8 Group Inc. Common Stock$0.302▼ 5.33%Market cap $70.73MP/E —$0.3132$0.98
- LABStandard BioTools Inc. Common Stock$0.63▼ 4.55%Market cap $313.21MP/E 2.92$0.6251$1.72
- PRPOPrecipio Inc. Common Stock$21.38▼ 5.17%Market cap $41.93MP/E —$16.4$33.63
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| QTRX Quanterix Corporation Common Stock | $180.42M | — | $2.87 | ▼ 6.51% | $2.15$8.77 |
| SEER Seer Inc. Class A Common Stock | $120.41M | — | $2.03 | ▼ 0.49% | $1.55$2.41 |
| NAUT Nautilus Biotechnology Inc. Common Stock | $112.76M | — | $2.06 | ▼ 4.63% | $0.8399$4.31 |
| RPID Rapid Micro Biosystems Inc. Class A Common Stock | $96.03M | — | $0.764 | ▼ 9.59% | $0.8087$4.94 |
| CIRC Circle8 Group Inc. Common Stock | $70.73M | — | $0.302 | ▼ 5.33% | $0.3132$0.98 |
| LAB Standard BioTools Inc. Common Stock | $313.21M | 2.92 | $0.63 | ▼ 4.55% | $0.6251$1.72 |
| PRPO Precipio Inc. Common Stock | $41.93M | — | $21.38 | ▼ 5.17% | $16.4$33.63 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- TD Cowen Maintains Hold on Quanterix, Raises Price Target to $3.5benzinga · 10/13/2026
- Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026Yahoo · 9/25/2026
- Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo · 9/17/2026
- Quanterix Names Dr. Yuri Fesko Chief Medical OfficerYahoo · 9/14/2026
Insider Activity
Insider Actions →- Ivana Magovcevic-Liebisch · October 2, 2026 · Option Exercise4.2K
- Scott Mendel · October 1, 2026 · Grant4.4K @ $3.41
- William P. Donnelly · October 1, 2026 · Grant7.0K @ $3.41
- Michael Francis Miller · September 15, 2026 · Option Exercise81
- Michael Francis Miller · September 15, 2026 · Tax Withholding249 @ $2.72
- Michael Francis Miller · September 15, 2026 · Tax Withholding111 @ $2.72
- Michael Francis Miller · September 15, 2026 · Tax Withholding41 @ $2.72
- Michael Francis Miller · September 15, 2026 · Tax Withholding25 @ $2.72
- Gute James Edward Jr. · September 15, 2026 · Grant260.3K
- Michael Francis Miller · September 15, 2026 · Option Exercise834
- Michael Francis Miller · September 15, 2026 · Option Exercise372
- Michael Francis Miller · September 15, 2026 · Option Exercise135
- Michael Francis Miller · September 15, 2026 · Option Exercise136
- Michael Francis Miller · August 31, 2026 · Option Exercise159
- Michael Francis Miller · August 31, 2026 · Tax Withholding48 @ $2.67
Institutional Ownership
March 31, 2026
- Total shares held
- 35.60M
- Total value held
- $124.55M
- Institutional holders
- 123
- Unknown3.54M
- Unknown3.28M
- Unknown2.95M
- Unknown2.14M
- Unknown2.08M
- Unknown1.93M
- Unknown1.78M
- Unknown1.46M
- Unknown1.30M
- Unknown994.8K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Quanterix Highlights Spatial Biology Innovation at ESSB 2026
Quanterix announced it met its spatial biology content innovation commitments during the ESSB 2026 event. The company showcased new tools and data sets that support advanced spatial analysis. This demonstrates progress in its product roadmap and may strengthen its position in the spatial biology market.
Quanterix Highlights Spatial Biology Innovation at ESSB 2026. Quanterix announced it met its spatial biology content innovation commitments during the ESSB 2026 event. The company showcased new tools and data sets that support advanced spatial analysis. This demonstrates progress in its product roadmap and may strengthen its position in the spatial biology market.